Mycophenolate mofetil in giant cell arteritis

Mycophenolate mofetil in giant cell arteritis

IntroductionGiant cell arteritis (GCA) is a systemic granulomatous vasculitis affecting the large arteries. Abnormal lymphocyte function has been noted as a pathogenic factor in GCA. Mycophenolate mofetil (MMF) inhibits inosine monophosphate dehydrogenase and is therefore a highly lymphocyte-specifi...

Full description

Bibliographic Details
Main Authors:	Anne Pankow, Sena Sinno, Thorsten Derlin, Marcus Hiss, Annette D. Wagner
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-11-01
Series:	Frontiers in Medicine
Subjects:	Mycophenolate mofetil giant cell arteritis vasculitis case series imaging
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2023.1254747/full

Similar Items

Mycophenolate mofetil and mycophenolic acid for the treatment of eosinophilic fasciitis: report of two cases and literature review
by: Ilse Andrea Moreno-Arquieta, et al.
Published: (2022-04-01)

Mycophenolate mofetil as an alternative treatment for autoimmune hepatitis
by: Seung Woon Park, et al.
Published: (2016-06-01)

Mycophenolate Mofetil and Clostridium difficile-associated Colitis
by: A. I. Dolgushina, et al.
Published: (2021-12-01)

The Role of Mycophenolate Mofetil for the Induction of Remission in ANCA-Associated Vasculitis: A Meta-Analysis
by: Anji Xiong, et al.
Published: (2021-03-01)

Mycophenolate mofetil therapy in adult patients with recalcitrant atopic dermatitis
by: David Dias-Polak, et al.
Published: (2019-01-01)

Autoimmune Ascites Responding to Mycophenolate Mofetil: A Case Report
by: Douglas A. Simonetto, et al.
Published: (2018-05-01)

Mycophenolate mofetil for the treatment of Henoch-Schönlein purpura nephritis; current knowledge and new concepts
by: Azar Nickavar, et al.
Published: (2017-07-01)

Effectiveness and safety of mycophenolate mofetil and rituximab combination therapy for immune idiopathic myopathies
by: Corrado Campochiaro, et al.
Published: (2024-04-01)

Comparison of mid-term clinical outcome in heart transplantation patients using mycophenolate mofetil vs. enteric-coated mycophenolate sodium
by: Kina Jeon, et al.
Published: (2022-08-01)

Management of erythema nodosum leprosum by mycophenolate mofetil
by: Banerjee Kalyan, et al.
Published: (2008-01-01)

Does mycophenolate mofetil increase the risk of cytomegalovirus infection in solid organ transplant recipients?: A mini-review
by: Alice Tung Wan Song, et al.

Mycophenolate mofetil as second line immunosuppressant in myasthenia gravis - a long-term prospective open-label study
by: Hanisch F, et al.
Published: (2009-08-01)

Acute pancreatitis induced by mycophenolate mofetil in a kidney transplant patient
by: Einollahi Behzad, et al.
Published: (2015-04-01)

The association of mycophenolate mofetil and human herpes virus infection
by: Jenny Sung Won Yun, et al.
Published: (2020-01-01)

Sites of gastrointestinal lesion induced by mycophenolate mofetil: a comparison with enteric-coated mycophenolate sodium in rats
by: Yichen Jia, et al.
Published: (2018-07-01)

Duodenal villous atrophy caused by Mycophenolate Mofetil in patients with solid organ transplantation: case report
by: Giuston Mendoza-Chuctaya, et al.
Published: (2016-03-01)

Mycophenolate mofetil-related colitis in a paediatric patient after kidney transplant
by: Natalia Oleksik, et al.
Published: (2022-10-01)

Mycophenolate Mofetil;A Review of Indications and Use in a Large Tertiary Hospital
by: Nimeshan Geevasinga, et al.
Published: (2005-12-01)

Mycophenolate mofetil and lichen planopilaris: systematic review and meta-analysis
by: Niyaz Mostafa, et al.
Published: (2022-01-01)

Mycophenolate mofetil and atopic dermatitis: systematic review and meta-analysis
by: Kevin Phan, et al.
Published: (2020-11-01)

Mycophenolate Mofetil-Induced Segmental Colitis Mimicking Ischemic Colitis
by: Kevin Johal, et al.
Published: (2014-03-01)

Risk of failing both methotrexate and mycophenolate mofetil from the First-line Antimetabolites as Steroid-sparing Treatment (FAST) uveitis trial
by: Amit K. Reddy, et al.
Published: (2023-06-01)

Mycophenolate mofetil in the treatment of non-renal manifestations of systemic lupus erythematosus: recent insights
by: Ali SAHIN
Published: (2010-05-01)

Clinical experience with mycophenolate mofetil in systemic autoimmune conditions refractory to common immunosuppressive therapies
by: C Bandelier
Published: (2009-01-01)

Mycophenolate mofetil‐induced peripheral neuropathy in the treatment of membranous glomerulonephropathy: A case report
by: Minoo Moghimi, et al.
Published: (2021-12-01)

Pharmacokinetics of mycophenolic acid and its effect on CD4+ and CD8+ T cells after oral administration of mycophenolate mofetil to healthy cats
by: Jennifer E. Slovak, et al.
Published: (2019-09-01)

Belimumab and low-doses of mycophenolate mofetil as induction therapy of class IV lupus nephritis: case series and literature review
by: Domenico Paolo Emanuele Margiotta, et al.
Published: (2018-03-01)

Tocilizumab for relapsing and remitting giant cell arteritis: a case series
by: Pratyasha Saha, et al.
Published: (2022-10-01)

Simultaneous Spectrophotometric Determination of Mycophenolate Mofetil and Its Active Metabolite in Human Plasma Using Chemometrics Methods
by: Tayyebeh Madrakian, et al.
Published: (2015-06-01)

Pharmacokinetics of Mycophenolate Mofetil and Development of Limited Sampling Strategy in Early Kidney Transplant Recipients
by: Jun Zhang, et al.
Published: (2018-08-01)

Effect of conversion from azathioprine to mycophenolate mofetil on renal function in stable kidney transplant recipients
by: Mehmet Usta, et al.
Published: (2019-10-01)

Successful Late Conversion to Mycophenolate Mofetil and Prednisone Immunosuppression Therapy in a Renal Transplant Recipient
by: Iqbal A, et al.
Published: (2000-01-01)

Mycophenolate mofetil versus cyclophosphamide for idiopathic membranous nephropathy; a double blind and randomized clinical trial
by: Fatemeh Hayati, et al.
Published: (2019-04-01)

Protective effect of melatonin and mycophenolate mofetil against nephrotoxicity induced by tacrolimus in wistar rats
by: Suleyman KOC, et al.
Published: (2021-11-01)

Long-term results of mycophenolate mofetil vs. azathioprine use in individuals with autoimmune hepatitis
by: George N. Dalekos, et al.
Published: (2022-12-01)

Efficacy and safety of mycophenolate mofetil in patients with IgA nephropathy: an update meta-analysis
by: Bing Du, et al.
Published: (2017-07-01)

Mycophenolate mofetil for systemic sclerosis: drug exposure exhibits considerable inter-individual variation—a prospective, observational study
by: Kristofer Andréasson, et al.
Published: (2020-10-01)

Efficacy and safety of mycophenolate mofetil in the treatment of moderate to severe Graves’ orbitopathy: a meta-analysis
by: Wenwen Feng, et al.
Published: (2022-06-01)

A comprehensive review of immunosuppressive drugs in pediatric dermatoses: Part II – methotrexate and mycophenolate mofetil
by: Shiti Bose, et al.
Published: (2022-01-01)

Giant cell arteritis: A case report and review of literature
by: Matthew A. Crain, BS, et al.
Published: (2021-12-01)